Asia-Pacific breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 9.7% during the forecast period. The key factors that augmenting the market in this region include the prevalence of breast cancer, awareness program by the government and private organizations. Breast cancer is the most common cancer in women in this country. Breast cancer has emerged as a major health issue in the region. Australia is estimated to have the highest rate of breast cancer incidences in the APAC region. The incidence rate of breast cancer in Australia was estimated to be around 86.0 per 100,000 women in 2015 as per Cancer Australia. Obesity, alcohol consumption and smoking are some of the major factors that are backing the increasing prevalence of breast cancer in Australia. Further, Singapore, Taiwan and Hong Kong also estimated to have a high incidence rate of breast cancer with 65.7, 65.9 and 61.2 per 100,000 women respectively as per WHO.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-breast-cancer-therapeutics-market
Asia-Pacific breast cancer therapeutics market is segmented on the basis of therapy. The therapy segment is further classified into chemotherapy, hormone therapy, targeted therapy, radiation therapy and others (surgery). Among all therapies, chemotherapy market held the largest market share in the Asia-Pacific breast cancer therapeutics market. Chemotherapy is most used when cancer in the lymph nodes and irrespective of tumor size or menopausal status. Along with that it is used for the treatment of breast cancer in premenopausal women and referred for those women who diagnosed with early stage breast cancer for hormone receptor negative and HER2 positive cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant chemotherapy. The adjuvant chemotherapy is used to destroy cancer cells that have been spread and not seen by the imaging tests. This method helps in reducing the cancer cells that form a new tumor in the other place of the body. Adjuvant chemotherapy reduces the risk of breast cancer coming back. Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can be removed with less widespread surgery.
The companies which are contributing to the growth of the Asia-Pacific breast cancer therapeutics market include AstraZeneca PLC, Eisai Co., Ltd., Bayer AG, GlaxoSmithKline PLC, Mylan NV, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.
Asia-Pacific Breast Cancer Therapeutics Market Segmentation
By Therapy
- Chemotherapy
- Hormone Therapy
- Targeted Therapy
- Radiation Therapy
- Others (Surgery)
A full report of Asia-Pacific Breast Cancer Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-breast-cancer-therapeutics-market
Regional Analysis
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- AbbVie Inc.
- AstraZeneca PLC
- Eisai Co., Ltd
- GlaxoSmithKline PLC
- Merck & Co., Inc.
- Novartis International AG
- Hoffmann-La Roche AG
- Pfizer Inc.
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
